IR: Establishing U.S. Presence for Series A Origenis Establishes and Consolidates Presence in U.S. Investor Community Establish company presence among U.S. investors and raise fund in the U.S. for a European central nervous system biotechnology company Created messages and revised corporate presentation (LHS Immersion®) Identified and conducted outreach to targeted U.S. investors and high value partners Organized and facilitated investor meetings at BIO Investor Forum, Bio-Europe, Biotech Showcase, Sachs Forums, and non-deal roadshow on the east coast Provided strategic counseling on Series A fundraising in the U.S. Introduced company to approximately 500 U.S. investors Initiated and managed more than 40 investor meetings both on site and via telecon Conducted substantial conversations with 7 investment firms under confidential disclosure agreement Currently in the process of finalizing a syndicate